evaluate the pharmaceuticals company ozempic on glp-1 medications Novo Nordisk's Ozempic® pill, only FDA-approved oral peptide medication for adults with type 2 diabetes, soon to be available in the US Ozempic Statistics: GLP-1 Weight Loss

These formulations are designed to mimic a natural hormone that supports satiety and slows gastric emptying

Epithalon and the Pineal Gland: Implications for Sleep and Aging

Ozeki et al (2022) found that GLP1-RA semaglutide effectively reduces body adiposity while maintaining the skeletal muscle mass in obese Type 2 Diabetic patients. Xiang et al (2023) had similar findings, semaglutide can reduce the weight and fat of obese patients while effectively maintaining muscle mass and muscle strength. Chen et al (2023) conducted a 3-month intervention using dulaglutide in patients with Type 2 Diabetes, noting , dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in body fat was independently associated with improved glucose control during dulaglutide therapy. With an increasing number of physicians and researchers relying on GLP-1 therapies for clinical care and research, it will continue to be crucial to track sensitive changes in body composition across different patient populations

Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters

21: 453 Neuman MG, Malkiewicz IM, Shear NH

Glutathione: actively combats dullness and provides the face with clarity